HIV/AIDS HAART
Reports add new data to HIV/AIDS HAART research
Published in AIDS Weekly, April 17th, 2006
Study 1: HIV protease mutations predict virological response of HIV-infected children to lopinavir/ritonavir salvage regimens.
"Lopinavir/ritonavir is a protease inhibitor (PI) that has shown great effectiveness as salvage therapy in PI-experienced HIV-infected children." In a recently published report, investigators in Spain conducted at study to determine "whether mutations in the HIV-1 protease gene can reliably predict virological responses to salvage therapy with lopinavir/ritonavir in HIV-infected children."
"We carried out a prospective study in 56...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-04-17)
More Articles from AIDS Weekly
- HIV/AIDS Drug Development
HIV-1 replication inhibited with small soluble Tat peptides - HIV/AIDS Pathogenesis
HIV-1 gag destabilizes gp120 and gp4l interaction - HIV/AIDS Pathogenesis
HIV-1 tropism switch from CCR5-to-CXR4 driven by naive and memory cell turnover - HIV/AIDS Vertical Transmission
CCR5 gene polymorphisms related to vertical HIV transmission risk - Hepatitis C & HIV Coinfection
Hepatitis C virus coinfection is associated with decreased adherence to antiretroviral therapy - Atherosclerosis
Atherosclerosis development is associated with antiretroviral HIV therapy - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
